NCT00428311View on ClinicalTrials.gov

Effects of Metformin vs Oral Contraceptives on CV Risk Markers in PCOS

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 30, 2004

Study Completion Date

October 31, 2006

Conditions
Polycystic Ovary Syndrome
Interventions
DRUG

Metformin

DRUG

Ethynyl-estradiol plus cyproterone acetate

Trial Locations (1)

E-28034

Department of Endocrinology, Hospital Ramón y Cajal, Madrid

All Listed Sponsors
lead

Hospital Universitario Ramon y Cajal

OTHER

NCT00428311 - Effects of Metformin vs Oral Contraceptives on CV Risk Markers in PCOS | Biotech Hunter | Biotech Hunter